---
figid: PMC11551650__WJGO-16-4338-g006
figtitle: C-MET pathway relays downstream signals to activate multiple oncogenic events
  to promote cell proliferation, migration, protein synthesis, and antiapoptosis
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11551650
filename: WJGO-16-4338-g006.jpg
figlink: /pmc/articles/PMC11551650/figure/F6/
number: F6
caption: 'The c-MET pathway relays downstream signals to activate multiple oncogenic
  events to promote cell proliferation, migration, protein synthesis, and antiapoptosis.
  The c-MET pathway transmits downstream signals by activating its receptor tyrosine
  kinase, triggering multiple carcinogenic events. This pathway activates signaling
  pathways such as RAS/mitogen-activated protein kinase, phosphoinositide 3-kinase/protein
  kinase B, and promotes cell proliferation, migration, protein synthesis, and anti-apoptosis.
  HGF: Hepatocyte growth factor; MEK: Mitogen-activated protein/extracellular signal-regulated
  kinase; ERK: Extracellular signal-regulated kinase; RAC: Ras-related C3 botulinum
  toxin substrate; JNK: Jun N-terminal kinase; BAD: Bcl-2-associated death promoter;
  mTOR: Mechanistic target of rapamycin; Grb2: Growth factor receptor-bound protein
  2; Gab1: Grb2-associated binder 1; STAT3: Signal transducer and activator of transcription
  3; MDM2: Mouse double minute 2; PI3K: Phosphoinositide 3-kinase; AKT: Protein kinase
  B; NF-κB: Nuclear factor kappa B; EGCG: Epigallocatechin gallate'
papertitle: Advances in the diagnosis and treatment of MET-variant digestive tract
  tumors
reftext: Chen Zhang, et al. World J Gastrointest Oncol. 2024 Nov 15;16(11).
year: '2024'
doi: 10.4251/wjgo.v16.i11.4338
journal_title: World Journal of Gastrointestinal Oncology
journal_nlm_ta: World J Gastrointest Oncol
publisher_name: Baishideng Publishing Group Inc
keywords: Digestive tract neoplasms | Interstitial epithelial transfer factor | Targeted
  therapy | MET variant | Survival prognosis
automl_pathway: 0.931223
figid_alias: PMC11551650__F6
figtype: Figure
redirect_from: /figures/PMC11551650__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11551650__WJGO-16-4338-g006.html
  '@type': Dataset
  description: 'The c-MET pathway relays downstream signals to activate multiple oncogenic
    events to promote cell proliferation, migration, protein synthesis, and antiapoptosis.
    The c-MET pathway transmits downstream signals by activating its receptor tyrosine
    kinase, triggering multiple carcinogenic events. This pathway activates signaling
    pathways such as RAS/mitogen-activated protein kinase, phosphoinositide 3-kinase/protein
    kinase B, and promotes cell proliferation, migration, protein synthesis, and anti-apoptosis.
    HGF: Hepatocyte growth factor; MEK: Mitogen-activated protein/extracellular signal-regulated
    kinase; ERK: Extracellular signal-regulated kinase; RAC: Ras-related C3 botulinum
    toxin substrate; JNK: Jun N-terminal kinase; BAD: Bcl-2-associated death promoter;
    mTOR: Mechanistic target of rapamycin; Grb2: Growth factor receptor-bound protein
    2; Gab1: Grb2-associated binder 1; STAT3: Signal transducer and activator of transcription
    3; MDM2: Mouse double minute 2; PI3K: Phosphoinositide 3-kinase; AKT: Protein
    kinase B; NF-κB: Nuclear factor kappa B; EGCG: Epigallocatechin gallate'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - HGF
  - IL6
  - SOS1
  - MET
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - MAPK8
  - MAPK9
  - MAPK10
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - BAD
  - AKT2
  - AKT3
  - MTOR
  - TK1
  - TK2
  - GRB2
  - GAB1
  - PIGU
  - STAT3
  - MDM2
  - NFKB1
  - TP53
  - TP63
  - TP73
  - EIF4EBP1
  - RPS6KB1
  - RPS6KB2
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MEK
  - RAS
  - Tyrosine kinase inhibitors
  - inhibitors
  - Protein
---
